Welcome to the Nakagawa Lab
Our Mission
Current Projects
Hypertension: The Silent Killer
Despite significant progress, cardiovascular (CV) diseases are still the leading cause of death globally. One of the main risk factors for CV disease is elevated blood pressure (BP) or hypertension (HT). High BP is typically managed with a wide variety of drugs. However, a vast number of patients with HT do not achieve desirable BP with conventional therapeutic options. Notably, patients who exhibit resistant HT are associated with autonomic imbalance and therefore, novel strategies to ameliorate sympathoexcitation and restore the depressed vagal parasympathetic tone (renal nerve ablation, vagus nerve stimulation, carotid baroreflex therapy, acetylcholinesterase inhibitors, etc.) are now recognized as potential therapeutic options for diseases beyond HT.
Thus, our laboratory’s main focus is to understand the fundamental neural mechanisms that control BP and the autonomic nervous system. We believe that our findings might contribute to developing new alternative therapies to treat HT.
(Fig. 1 - right)
The Brain RAS: A Fundamental Mechanism of Blood Pressure Control
Although the critical role of the local activation of the RAS in the brain to control BP regulation, hydromineral balance, autonomic function, and metabolism is well accepted it remains unclear how and where angiotensin (ANG)-II, the main bioactive component of the RAS, is generated within the brain; Surprisingly, whether renin, the rate-limiting enzyme of ANG-II biosynthesis, is expressed and necessary for the cleavage of angiotensinogen (AGT) to generate ANG-I in the brain remains controversial.
(Fig. 2 - left)
Unraveling a Scientific Mystery That Has Persisted for 5 Decades: the Discovery of Renin-Expressing Neurons in the Nucleus Ambiguus
For many years, conventional techniques that are normally used to detect the abundant amounts of renin in plasma and kidneys have been used in an attempt to detect renin in whole brain tissue homogenates. But these methods lack sensitivity, specificity, and especially the anatomical precision to detect neurons that produce extremely low amounts of renin. Thus, these questionable reports raised a misconception that renin is not expressed in the brain. Our team has mastered key technology from neuroscience and acquired expertise in neuroanatomy to address this important question with the appropriate tools and techniques. These advanced techniques and new knowledge helped us to obtain convincing evidence for the expression of renin in cholinergic neurons within the brainstem, specifically, the nucleus ambiguus (NuAm), which is a relatively understudied brainstem region in the field of hypertension (Fig. 3).
This exciting discovery is critical since the existence of a select population of neurons expressing renin incorporates new evidence that ANG might operate as a neurotransmitter in the brain. There are two main theories about this topic: a) the volume transmission hypothesis where ANG peptides are generated in the extracellular space acting as neurohormones, and b) the wiring transmission hypothesis where ANG generated by neurons acts as a neurotransmitter itself. Although several studies support the second possibility, the lack of evidence that renin is expressed in neurons has been the major limitation in defining ANG as a neurotransmitter. Thus, the identification of the renin-neurons in the NuAm could be an important finding to solve this critical question. Cellular, molecular, and neurobiological characterization of renin-expressing neurons will provide key information to understand how the RAS operates in the brain and ensure definitive evidence of the functional role of renin in the brain.
(Fig. 3)
New Advances: Characterizing the Novel Renin-Expressing Neurons Using State-of-the-Art Technology
(Fig. 4)
(Fig. 5)
Meet Our Team
Pablo Nakagawa, PhD
Assistant Professor
Eva Fekete, PhD
Research Scientist
Mina Ghobrial
G2 Student
Ana Hantke Guixa, BS
Research Technologist I
Katie Kaminski
Graduate Student
Haruka Okabe, MS
Research Technologist I
Publications
-
(Mathieu NM, Tan EE, Reho JJ, Brozoski DT, Muskus PC, Lu KT, Wackman KK, Grobe JL, Nakagawa P, Sigmund CD.) Hypertension. 2024 Jun;81(6):1332-1344 PMID: 38629290 PMCID: PMC11096025 SCOPUS ID: 2-s2.0-85193429264 04/17/2024
-
(Reho JJ, Muskus PC, Bennett DM, Grobe CC, Burnett CML, Nakagawa P, Segar JL, Sigmund CD, Grobe JL.) Am J Physiol Regul Integr Comp Physiol. 2024 Mar 01;326(3):R242-R253 PMID: 38284128 PMCID: PMC11213288 SCOPUS ID: 2-s2.0-85186271298 01/29/2024
-
(Mathieu NM, Nakagawa P, Grobe JL, Sigmund CD.) Hypertension. 2024 Jan;81(1):6-16 PMID: 37449411 PMCID: PMC10787814 SCOPUS ID: 2-s2.0-85180800778 07/14/2023
-
(Ziegler AA, Lawton SBR, Grobe CC, Reho JJ, Freudinger BP, Burnett CML, Nakagawa P, Grobe JL, Segar JL.) Am J Physiol Regul Integr Comp Physiol. 2023 Nov 01;325(5):R576-R592 PMID: 37720996 PMCID: PMC10866575 SCOPUS ID: 2-s2.0-85174752582 09/18/2023
-
(Grobe CC, Reho JJ, Brown-Williams D, Ziegler AA, Mathieu NM, Lawton SBR, Fekete EM, Brozoski DT, Wackman KK, Burnett CML, Nakagawa P, Sigmund CD, Segar JL, Grobe JL.) Hypertension. 2023 Sep;80(9):1871-1880 PMID: 37470185 PMCID: PMC10528934 SCOPUS ID: 2-s2.0-85168254483 07/20/2023
-
(Balapattabi K, Yavuz Y, Jiang J, Deng G, Mathieu NM, Ritter ML, Opichka MA, Reho JJ, McCorvy JD, Nakagawa P, Morselli LL, Mouradian GC Jr, Atasoy D, Cui H, Hodges MR, Sigmund CD, Grobe JL.) Cell Rep. 2023 Aug 29;42(8):112935 PMID: 37540598 PMCID: PMC10530419 SCOPUS ID: 2-s2.0-85169503465 08/04/2023
-
(Mathieu NM, Fekete EM, Muskus PC, Brozoski DT, Lu KT, Wackman KK, Gomez J, Fang S, Reho JJ, Grobe CC, Vazirabad I, Mouradian GC Jr, Hodges MR, Segar JL, Grobe JL, Sigmund CD, Nakagawa P.) Function (Oxf). 2023;4(5):zqad043 PMID: 37609445 PMCID: PMC10440998 SCOPUS ID: 2-s2.0-85168790693 08/23/2023
-
(Wagner VA, Deng G, Claflin KE, Ritter ML, Cui H, Nakagawa P, Sigmund CD, Morselli LL, Grobe JL, Kwitek AE.) Front Cell Neurosci. 2023;17:1207350 PMID: 37293629 PMCID: PMC10244568 SCOPUS ID: 2-s2.0-85161193387 06/09/2023
-
(Ritter ML, Deng G, Reho JJ, Deng Y, Sapouckey SA, Opichka MA, Balapattabi K, Wackman KK, Brozoski DT, Lu KT, Paradee WJ, Gibson-Corley KN, Cui H, Nakagawa P, Morselli LL, Sigmund CD, Grobe JL.) Hypertension. 2022 Dec;79(12):2843-2853 PMID: 36259376 PMCID: PMC9649888 SCOPUS ID: 2-s2.0-85141891708 10/20/2022
-
(Mathieu NM, Nakagawa P, Grobe CC, Reho JJ, Brozoski DT, Lu KT, Wackman KK, Ritter ML, Segar JL, Grobe JL, Sigmund CD.) Hypertension. 2022 Nov;79(11):2480-2492 PMID: 36215165 PMCID: PMC9669141 SCOPUS ID: 2-s2.0-85140375825 10/11/2022
-
(Oliveira V, Reho JJ, Balapattabi K, Ritter ML, Mathieu NM, Opichka MA, Lu KT, Grobe CC, Silva SD Jr, Wackman KK, Nakagawa P, Segar JL, Sigmund CD, Grobe JL.) Am J Physiol Regul Integr Comp Physiol. 2022 Oct 01;323(4):R410-R421 PMID: 35816717 PMCID: PMC9512112 SCOPUS ID: 2-s2.0-85138457982 07/12/2022
-
(Mouradian GC Jr, Liu P, Nakagawa P, Duffy E, Gomez Vargas J, Balapattabi K, Grobe JL, Sigmund CD, Hodges MR.) Front Synaptic Neurosci. 2022;14:910820 PMID: 35844900 PMCID: PMC9280690 SCOPUS ID: 2-s2.0-85134237459 07/19/2022